To screen for novel PSMA-specific peptide to be used as targeting ligands and targeted drug delivery to prostate cancer cells, Jin et al. identified PSMA-specific peptides through combinatorial phage display techniques. This evidence concerns the gene FOLH1 and prostate cancer.